|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 245.00 USD | +0.82% |
|
-2.76% | +6.46% |
| 08-07 | Haisco Pharmaceutical Gets China Clinical Trial Nod for Migraine Treatment; Shares Rise 4% | MT |
| 08-06 | RemeGen Expects to Return to Profit in H1; Hong Kong Shares Down 3% | MT |
| Market Cap | 435B 376B 351B 322B 606B 41,379B 616B 4,121B 1,617B 20,740B 1,633B 1,597B 68,566B | P/E 2026 * |
32.3x | P/E 2027 * | 23.3x |
|---|---|---|---|---|---|
| Enterprise Value | 497B 430B 402B 369B 693B 47,333B 704B 4,713B 1,850B 23,725B 1,868B 1,827B 78,432B | EV / Sales 2026 * |
7.35x | EV / Sales 2027 * | 6.65x |
| Free-Float |
95.71% | Yield 2026 * |
2.81% | Yield 2027 * | 2.94% |
Last Transcript: AbbVie Inc.
| 1 day | +0.82% | ||
| 1 week | -2.76% | ||
| Current month | -2.76% | ||
| 1 month | -3.81% | ||
| 3 months | +20.58% | ||
| 6 months | +9.53% | ||
| Current year | +6.46% |
| 1 week | 241 |  | 259.45 |
| 1 month | 233 | | 273.25 |
| Current year | 186.49 | | 273.25 |
| 1 year | 186.49 | | 273.25 |
| 3 years | 135.96 | | 273.25 |
| 5 years | 105.59 | | 273.25 |
| 10 years | 50.38 | | 273.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 2024-06-30 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 2022-06-22 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 2012-12-31 |
William Burnside
BRD | Director/Board Member | 74 | 2012-12-31 |
Ed Rapp
BRD | Director/Board Member | 69 | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.82% | -2.76% | - | - | 431B | |
| -0.52% | +3.21% | +85.02% | +161.12% | 1,062B | |
| +0.88% | +1.13% | +51.13% | +49.76% | 619B | |
| +0.89% | -1.95% | +23.73% | +63.67% | 431B | |
| +0.71% | +3.87% | +47.45% | +38.68% | 358B | |
| +0.64% | -0.49% | +35.39% | +40.21% | 293B | |
| +0.39% | -5.83% | +8.64% | +9.28% | 247B | |
| +1.51% | +6.69% | +44.34% | +62.47% | 219B | |
| +3.92% | -0.46% | -1.21% | -44.09% | 200B | |
| +1.80% | +2.30% | +20.79% | +65.13% | 162B | |
| Average | +1.26% | -0.50% | +35.03% | +49.58% | 399.14B | |
| Weighted average by Cap. | +1.08% | +0.49% | +48.59% | +75.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.62B 58.49B 54.62B 50.11B 94.25B 6,436B 95.75B 641B 252B 3,226B 254B 248B 10,664B | 73.7B 63.75B 59.53B 54.61B 103B 7,014B 104B 698B 274B 3,516B 277B 271B 11,622B |
| Net income | 13.96B 12.08B 11.28B 10.35B 19.46B 1,329B 19.77B 132B 51.94B 666B 52.43B 51.29B 2,202B | 19.02B 16.46B 15.37B 14.1B 26.51B 1,811B 26.94B 180B 70.77B 907B 71.44B 69.88B 3,000B |
| Net Debt | 62.56B 54.12B 50.54B 46.36B 87.2B 5,954B 88.58B 593B 233B 2,984B 235B 230B 9,866B | 55.04B 47.61B 44.46B 40.78B 76.71B 5,238B 77.92B 522B 205B 2,625B 207B 202B 8,679B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | US$244.71 | +0.67% | 4,590 |
| 26-08-06 | US$243.08 | -1.17% | 7,622 |
| 26-08-05 | US$245.97 | +1.25% | 9,744 |
| 26-08-04 | US$242.94 | -1.44% | 115,984 |
| 26-08-03 | US$246.48 | -2.17% | 6,092 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
- 0QCV Stock
Select your edition
All financial news and data tailored to specific country editions
